Summary
Updated Aug 31, 2026
Geraldine Pannu is Director of Processa Pharmaceuticals, Inc. (PCSA). 6 SEC Form 4 filings on record going back to 2025, most recently on 29 July 2026. Most recent open-market trade: bought $5K of PCSA on 1 April 2026. Lifetime open-market purchases: $5K.
Recent Transactions
4Every recent SEC Form 4 transaction Geraldine Pannu has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Geraldine Pannu files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Russell Skibsted - $42K of PCSA open-market activity in the last 12 months
- George K. Ng - $39K of PCSA open-market activity in the last 12 months
- Wendy Guy - $33K of PCSA open-market activity in the last 12 months
- David Young - $32K of PCSA open-market activity in the last 12 months
- Patrick Lin - $28K of PCSA open-market activity in the last 12 months
- Sian Bigora - $21K of PCSA open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Geraldine Pannu?
Geraldine Pannu is a corporate insider, tracked as Director of Processa Pharmaceuticals, Inc. (PCSA). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Geraldine Pannu submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Geraldine Pannu been buying or selling stock?
Recorded transactions: 1 open-market purchase ($5K) and 0 open-market sales across all tracked filings.
Where can I see all of Geraldine Pannu's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Geraldine Pannu and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
